By Robert Preidt
HealthDay Reporter

TUESDAY, June 16, 2020 (HealthDay News) — An experimental blood examination may perhaps enhance screening for the most frequent variety of liver cancer, researchers at the U.S. National Cancer Institute say.

The examination checks people today for previous exposure to particular viruses that may perhaps interact with the immune program and maximize the chance of hepatocellular carcinoma (HCC), according to their new examine.

“Together with current screening exams, the new examination could enjoy an essential job in screening people today who are at chance for establishing HCC. It could assistance